A Clinical Randomised Control Study On Efficacy Of â??Kiratadi Kwathâ?? In Tamak Shvasa With Special Reference To Bronchial Asthma .

Government Ayurved CollegeNagpur0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1) Patients having sign and symptoms of tamak shvasa according to classics.
•2) Patient showing symptoms, sign and medical history of bronchial asthma will be included.
•3) Patients having respiratory rate in between 22 to 42 per minute will be included.
•4) Patients suffering from this disease since 1 to 4 years will be included in study.
•5) Patient with mild to moderate exacerbation of Bronchial asthma
•6)patient willing and able to participate for 2 months.
•7) Positive test of reversibility:
•a] symptomatic patients - An improvement of 60 L/min or >20% in PEFR 10 min after inhalation of bronchodilator.
•b] Asymptomatic patient 60 L/min or >20% fall in PEFR by provocation with 5-10 min of physical exercise followed by reversal upon inhalation of bronchodilator when assessed after 10 min.

•1) Patients having major diseases like AIDS, renal and cardio vascular diseases will be rejected.
•2) If any patient discontinues the treatment will be excluded from this study.
•3) Patients with severe asthma exacerbation.
•4) Patient who is pregnant or lactating will be excluded.
•5) Patients with poorly controlled Hypertension [ >160/100mmhg]
•6) Patients with uncontrolled Diabetes Mellitus [ Blood sugar fasting > 130 mg / dl and post meal 250 mg / dl]
•7) Patients with active lung disease other than Bronchial asthma.
•8) Patients who had major surgery within 2 weeks prior to screening visited.
•9) Patients with a known diagnosis of human immunodeficiency virus.
•10) Patients with evidence of malignancy.

发起方

Government Ayurved CollegeNagpur